Ausgabe 3/2021
Inhalt (30 Artikel)
Undercutting efforts of precision medicine: roadblocks to minority representation in breast cancer clinical trials
Geetanjali Saini, Keerthi Gogineni, Rick A. Kittles, Ritu Aneja
Concurrent mutations associated with trastuzumab-resistance revealed by single cell sequencing
Yan Gao, Ning Wu, Shuai Wang, Xue Yang, Xin Wang, Bo Xu
Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer
Sandeep Kumar, Amanjit Bal, Ashim Das, Ishita Loriya, Siddhant Khare, Shalmoli Bhattacharya, Gurpreet Singh
The role of infiltrating lymphocytes in the neo-adjuvant treatment of women with HER2-positive breast cancer
A. J. Eustace, S. F. Madden, J. Fay, D. M. Collins, E. W. Kay, K. M. Sheehan, S. Furney, B. Moran, A. Fagan, P. G. Morris, A. Teiserskiene, A. D. Hill, L. Grogan, J. M. Walshe, O. Breathnach, C. Power, D. Duke, K. Egan, W. M. Gallagher, N. O’Donovan, J. Crown, S. Toomey, B. T. Hennessy
Comparison of survival outcomes for axillary surgery extent based on intraoperative sentinel lymph node biopsy result after neoadjuvant chemotherapy for breast cancer
Jung Whan Chun, Jisun Kim, I. I. Yong Chung, Beom Seok Ko, Hee Jeong Kim, Jong Won Lee, Byung Ho Son, Sei-Hyun Ahn, Sae Byul Lee
Bystander effects induced by electron beam-irradiated MCF-7 cells: a potential mechanism of therapy resistance
Maryam Feghhi, Jafar Rezaie, Kamal Mostafanezhad, Nasrollah Jabbari
Unveiling the histopathologic spectrum of MRI-guided breast biopsies: an institutional pathological-radiological correlation
Gustavo Moreno, Mariel Molina, Ruizhe Wu, Julie R. Sullivan, Julie M. Jorns
Comparison of hormone-induced mRNA and protein biomarker expression changes in breast cancer cells
Sarah M. Bernhardt, Pallave Dasari, Danielle J. Glynn, Amanda R. Townsend, Timothy J. Price, Wendy V. Ingman
Combinatorial targeting of microRNA-26b and microRNA-101 exerts a synergistic inhibition on cyclooxygenase-2 in brain metastatic triple-negative breast cancer cells
Rania Harati, Aloïse Mabondzo, Abdelaziz Tlili, Ghalia Khoder, Mona Mahfood, Rifat Hamoudi
Adjuvant chemotherapy for breast cancer patients with axillary lymph node micrometastases
Madeleine Hetterich, Michael Gerken, Olaf Ortmann, Elisabeth C. Inwald, Monika Klinkhammer-Schalke, Holm Eggemann, Atanas Ignatov
Every Day Counts: a randomized pilot lifestyle intervention for women with metastatic breast cancer
Patricia Sheean, Lauren Matthews, Alexis Visotcky, Anjishnu Banerjee, Andrea Moosreiner, Kimberly Kelley, Christopher R. Chitambar, Paula E. Papanek, Melinda Stolley
Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies
Alexi Surette, Byong Hoon Yoo, Tallal Younis, Kara Matheson, Tarek Rameh, Jaime Snowdon, Gillian Bethune, Kirill V. Rosen
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study
Chiun-Sheng Huang, Youngsen Yang, Ava Kwong, Shin-Cheh Chen, Ling-Ming Tseng, Mei-Ching Liu, Kunwei Shen, Shusen Wang, Ting-Ying Ng, Yi Feng, Guofang Sun, Iris Renfei Yan, Zhimin Shao
Monitoring serum estradiol levels in breast cancer patients during extended adjuvant letrozole treatment after five years of tamoxifen: a prospective trial
Mária Faltinová, Leena Vehmanen, Heli Lyytinen, Mikko Haanpää, Esa Hämäläinen, Aila Tiitinen, Carl Blomqvist, Johanna Mattson
A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)
Laila A. Gharzai, Lauren A. Szczygiel, Dean A. Shumway, Hanna Bandos, Thomas B. Julian, Eleftherios P. Mamounas, Julia White, Jennifer F. De Los Santos, Mark Basik, Patricia A. Ganz, Reshma Jagsi
Analysis of the tumor characteristics in young age breast cancer patients using collaborative stage data of the Korea Central Cancer Registry
Junyup Kim, Seri Hong, Jae Jun Lee, Young-Joo Won, Eun Sook Lee, Han-Sung Kang, Seeyoun Lee, Jai Hong Han, Eun-Gyeong Lee, Heein Jo, Hyun Hee Kim, So-Youn Jung
Associations of one-carbon metabolism-related gene polymorphisms with breast cancer risk are modulated by diet, being higher when adherence to the Mediterranean dietary pattern is low
Shang Cao, Zheng Zhu, Jinyi Zhou, Wei Li, Yunqiu Dong, Yun Qian, Pingmin Wei, Ming Wu
Refining breast cancer prognosis by incorporating age at diagnosis into clinical prognostic staging: introduction of a novel online calculator
Helen M. Johnson, William Irish, Nasreen A. Vohra, Jan H. Wong
Outcomes of HER2-positive non-metastatic breast cancer patients treated with anti-HER2 therapy without chemotherapy
Susanna Nguy, S. Peter Wu, Cheongeun Oh, Naamit K. Gerber
Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study
Mary Falcone, Lihua Liu, Albert Farias, JuanJuan Zhang, Irene Kang, Ming Li, Mariana C. Stern, Caryn Lerman
Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry
José P. Leone, Bernardo A. Leone, Nabihah Tayob, Michael J. Hassett, Julieta Leone, Rachel A. Freedman, Sara M. Tolaney, Eric P. Winer, Carlos T. Vallejo, Nancy U. Lin
Survival of women diagnosed with breast cancer and who have survived a previous cancer
Sandi L. Pruitt, Hong Zhu, Daniel F. Heitjan, Asal Rahimi, Bhumika Maddineni, Anna Tavakkoli, Ethan A. Halm, David E. Gerber, Danyi Xiong, Caitlin C. Murphy
Time-varying effects of FOXA1 on breast cancer prognosis
Qian-xin Chen, Yuan-zhong Yang, Zhuo-zhi Liang, Jia-li Chen, Yue-lin Li, Zi-yi Huang, Zi-jin Weng, Xiao-fang Zhang, Jie-xia Guan, Lu-ying Tang, Jing-ping Yun, Ze-fang Ren
Delayed initiation of adjuvant chemotherapy among women with breast cancer in Addis Ababa, Ethiopia
Alem Gebremariam, Mathewos Assefa, Adamu Addissie, Alemayehu Worku, Nebiyu Dereje, Aynalem Abreha, Wondemagegnehu Tigeneh, Lydia E. Pace, Eva Johanna Kantelhardt, Ahmedin Jemal
Real-world evidence from a University Hospital system regarding the uptake of adjuvant pertuzumab and/or neratinib before and after their FDA approval
Ericson Stoen, Jodi Kagihara, Elena Shagisultanova, Christine M. Fisher, Andrew Nicklawsky, Peter Kabos, Virginia F. Borges, Jennifer R. Diamond
Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study
Monica Tang, Andrea L. Schaffer, Belinda E. Kiely, Benjamin Daniels, Chee K. Lee, Robert J. Simes, Sallie-Anne Pearson
Recurrence rates in patients with HER2+ breast cancer who achieved a pathological complete response after neoadjuvant pertuzumab plus trastuzumab followed by adjuvant trastuzumab: a real-world evidence study
Joyce O’Shaughnessy, Nicholas Robert, Srinivas Annavarapu, Jie Zhou, Jesse Sussell, Anna Cheng, Anita Fung
Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach
Parinita. K. Swarnkar, Kefah Mokbel
Association between rice consumption and risk of cancer incidence in the California Teachers Study
Rebecca J. Austin-Datta, Carmen R. Smotherman, Lusine Yaghjyan
Patterns of invasive recurrence among patients originally treated for ductal carcinoma in situ by breast-conserving surgery versus mastectomy
Parinita K. Swarnkar, Kefah Mokbel